ArticlePDF Available

CAROTID BLOWOUT SYNDROME DURING RADIOTHERAPY: A CASE PRESENTATION AND REVIEW OF A RARE ENTITY

Authors:

Abstract and Figures

Carotid blowout syndrome (CBS) is an uncommon but a potentially lethal complication with 40% mortality and 60% morbidity, encountered in head and neck cancer patients. CBS has three subtypes; threatened, impending, acute. Impending form is characterized by spontaneously resolving recurrent epistaxis attacs. Radical neck dissection, pharyngocutaneous fistulae, recurrent/ residual tumor and irradiation have been determined as potential risk factors of CBS. Nasopharyngeal carcinoma is highly radiosensitive and its primary treatment is radiotherapy. We report a 77-year-old male patient with T4N2cM0 nasopharyngeal cancer with impending form of CBS diagnosed during the initial days of radiation.
Content may be subject to copyright.
Bahar KAYAHAN, MD; Nilda SÜSLÜ, MD; Cavid CABBARZADE, MD; Gamze ATAY, MD; Gözde YAZICI, MD; Ali
Şefik HOŞAL, MD
Carotid Blowout Syndrome During Radiotherapy: A Case Presentation and Review of A Rare Entity
KBB-Forum
2013;12(3)
www.KBB-Forum.net
CASE REPORT
CAROTID BLOWOUT SYNDROME DURING RADIOTHERAPY: A CASE
PRESENTATION AND REVIEW OF A RARE ENTITY
Bahar KAYAHAN, MD1; Nilda SÜSLÜ, MD1; Cavid CABBARZADE, MD1; Gamze ATAY, MD1;
Gözde YAZICI, MD2; Ali Şefik HOŞAL, MD1
1Hacettepe, Kulak Burun Boğaz ve Baş Boyun Cerrahisi, Ankara, Türkiye 2Hacettepe, Radyasyon Onkolojisi, Ankara, Türkiye
SUMMARY
Carotid blowout syndrome (CBS) is an uncommon but a potentially lethal complication with 40% mortality and 60% morbidity,
encountered in head and neck cancer patients. CBS has three subtypes; threatened, impending, acute. Impending form is characterized by
spontaneously resolving recurrent epistaxis attacs. Radical neck dissection, pharyngocutaneous fistulae, recurrent/ residual tumor and
irradiation have been determined as potential risk factors of CBS. Nasopharyngeal carcinoma is highly radiosensitive and its primary
treatment is radiotherapy. We report a 77-year-old male patient with T4N2cM0 nasopharyngeal cancer with impending form of CBS
diagnosed during the initial days of radiation.
Keywords: Nasopharyngeal cancer, Radiotherapy
RADYOTERAPİ SIRASINDA ‘‘CAROTİD BLOWOUT'' SENDROMU: OLGU SUNUMU VE BU NADİR DURUMUN
GÖZDEN GEÇİRİLMESİ
ÖZET
‘‘Carotid blowout'' sendromu (CBS), baş boyun kanserli hastalarda görülen, sık rastlanmayan ancak %40 mortalite ve %60 morbidite
oranları ile yüksek riske sahip bir komplikasyondur. CBS üç alt gruptan oluşmaktadır; akut, subakut-yaklaşan ve yavaş-gizli ilerleyen.
Subakut-yaklaşan tip CBS'de tekrarlayan ve kendiliğinden duran diffüz kanamalar görülmektedir. Radikal boyun diseksiyonu,
faringokutanöz fistül, nüks / rezidü tümör varlığı ve radyoterapi hikayesi CBS için potansiyel risk faktörleridir. Nazofarinks kanserinin
oldukça radyosensitif olması nedeniyle primer tedavisi radyoterapidir. Bu yazıda T4N2cM0 evreli nazofarinks kanseri olan, primer
radyoteraipinin erken günlerinde subakut - yaklaşan tip CBS gelişerek exitus olan 77 yaşında bir erkek hasta sunulmuştur.
Anahtar Sözcükler: Nazofarenks kanseri, Radyoterapi
INTRODUCTION
Carotid blowout syndrome (CBS) is a life-
threatening condition which is defined as rupture or
exposure of carotid artery.1,2 It is a potentially lethal
complication in patients with head and neck cancer.
CBS has an average mortality rate of 40 % and
morbidity rate of 60%.3,4 Radical neck dissection,
pharyngocutaneous fistulae, irradiation, recurrent or
residual tumor have been implicated as potential
causes of CBS.3-6 Nasopharyngeal cancer is a
radiosensitive tumor and the primary treatment is
radiotherapy with or without chemotherapy
depending on the stage.5,7 Although radiation induced
CBS with pseudoaneurysm formation is an
uncommon complication in nasopharyngeal cancer,
several reports had declared cases with
pseudoaneurysm of petrous segment of internal
carotid artery.1,5,7-10
Corresponding Author: Cavid Cabbarzade MD; Hacettepe,
Kulak Burun Boğaz ve Baş Boyun Cerrahisi, Ankara, Türkiye, E-mail:
drcavidcab@yahoo.com
Received: 17 June 2013, revised for: 26 July 2013, accepted
for publication: 28 July 2013
In this paper, an adult patient who had been on
radiotherapy due to nasopharyngeal cancer and
developed CBS during initialdays of treatement is
presented and literature regarded CBS is reviewed.
CASE PRESENTATION
A 77-year old male patient admitted to our clinic with
bilateral neck masses. Otolaryngological examination
revealed an ulcerative mass on postero-superior wall
of nasopharynx, several conglomerated
lymphadenopathies on bilateral level II and V and
right vocal cord paralysis. From his past medical
history, it was learned that he had an ischemic
cerebrovascular attack twenty years ago and he has
diabetes mellitus type II. Magnetic Resonance
Imaging revealed a mass in nasopharynx which was
invading cavernous sinus and prevertebral muscles;
and there were metastatic cervical
lymphadenopathies in level II-III-V bilaterally.
Histopathological diagnosis of the nasopharyngeal
mass was non-keratinized undifferentiated
nasopharyngeal cancer. Patient was diagnosed as
T4N2cM0 nasopharyngeal cancer, and concomittant
chemoradiotherapy was planned. Seventy Gy with a
104
Bahar KAYAHAN, MD; Nilda SÜSLÜ, MD; Cavid CABBARZADE, MD; Gamze ATAY, MD; Gözde YAZICI, MD; Ali
Şefik HOŞAL, MD
Carotid Blowout Syndrome During Radiotherapy: A Case Presentation and Review of A Rare Entity
KBB-Forum
2013;12(3)
www.KBB-Forum.net
fraction dose of 2 Gy to gross tumor volume, 66 Gy
to whole nasopharynx and positive lymph nodes was
planned with intensity modulated radiotherapy
technique. Cisplatinium, with a dose of 35 mg/m2/
week, was planned concomitantly with radiotherapy.
On the 18th day of radiotherapy, patient admitted to
the emergency clinic with epistaxis. He stated that he
had several episodes of bleeding all of which
resolved spontaneously during the last three days. In
the emergency clinic, hemoglobin level was detected
to be 8.9 mg/dl. On otolaryngological examination an
oozing type epistaxis originating from the
nasopharyngeal mass was noticed. The bleeding was
controlled with simple transnasal packing. He was
hospitalized and two unites of red blood cells were
transfused. After the patient was stabilized in
hemodynamic means, an angiography with
computerized tomography was performed with
suspicion of pseudoaneurysm on internal carotid
artery wall. It was detected that a 9 mm left internal
carotid artery pseudoaneurysm was present with
certain amount of extravasation (Figure 1, 2). The
patient was consulted with interventional
neuroradiology and stenting of the internal carotid
artery segment with pseudoaneurysm was planned.
Just after the radiological imaging was performed;
patient had a profuse epistaxis and he deteriorated
rapidly. He had a filliform pulse with remarkable
hypotension. He was intubated and resuscitation was
started immediately. He was given proper fluid
support intravenously and atropine, adrenaline,
bicarbonate by close monitoring. Bleeding continued
during resuscitation and at the end of an hour patient
was accepted as exitus.
DISCUSSION
Carotid blowout syndrome might be
observed due to head and neck tumor itself or the
treatment modality. Not only a part of carotid artery
could be infiltrated by tumor or its neck metastasis;
but also it could be nuded or damaged by treatment
modalities such as neck dissection or irradiation.4,11
In the treatment of nasopharyngeal cancer,
radiotherapy is being administered to the primary site
and neck bilaterally. Large arteries are relatively
resistant to radiotherapy however stenosis may be
observed even in large vessels following
radiotherapy. This side effect is a delayed
complication of radiotherapy and is observed years
after treatement. Carotid blowout syndrome is a rare
complication of radiotherapy and usually occurs after
re-irradiation. In a review which was published
recently, the rate of CBS was 2.6% for patients
receiving salvage head and neck reirradiation.12 The
median time to CBS, which was measured from the
begining of reirradiation was 7.5 months. In this
review, patients receiving reirradiation with
stereotactic body radiotherapy (SBRT) were
excluded. The rate of CBS in patients receiving
salvage radiotherapy with SBRT is reported to be in
the range of 10% to 17%.13,14 It is observed during 5
to 24 months following SBRT.
Figure 1: Pseudoaneurysm formation on left internal
carotid artery, petrocavernous junction (Computed
Tomography Angiography).
Figure 2: Pseudoaneurysm formation on left internal
carotid artery, petrocavernous junction (Computed
Tomography Angiography).
105
Bahar KAYAHAN, MD; Nilda SÜSLÜ, MD; Cavid CABBARZADE, MD; Gamze ATAY, MD; Gözde YAZICI, MD; Ali
Şefik HOŞAL, MD
Carotid Blowout Syndrome During Radiotherapy: A Case Presentation and Review of A Rare Entity
KBB-Forum
2013;12(3)
www.KBB-Forum.net
Radiotherapy is involved in pathophysiology
of CBS as it can lead to vascular pathologies such as
obliteration of vaso vasorum, adventitial fibrosis,
atherosclerosis, weakening of arterial wall,
subendothelial vacoulization, fragmentation of tunica
media elastic fibers of the carotid artery.6,7,10
Irradiation may also cause osteonecrosis of petrosal
bone which is critical in formation of
pseudoaneurysm at petrosal segment of carotid artery
which can trigger CBS.7,8 Recurrent cases require
booster doses of radiotherapy which makes carotid
artery, particularly the petrous segment, more
vulnerable to pseudoaneurysm formation and further
bleeding.5,7 Our case is unusual, as the damage to the
large vessel was seen during the first line
radiotherapy, whereas in literature CBS is usually
reported with reirradiation or after the conclusion of
therapy.1,2,5,8
Neck dissection is known as another
etiologic factor for CBS. Postoperative complications
after neck dissection, such as flap necrosis, wound
infection, pharyngocutaneous fistula formation may
cause arterial wall damage and injuries of carotid
artery.5,6,15
Carotid blowout syndrome is classified into
three subtypes; threatened, impending and acute.
Threatened CBS is defined as exposure of the carotid
artery due to wound breakdown or neoplastic
invasion of carotid system although hemorrhage has
not occured yet. If the carotid artery is not promptly
covered with healthy tissue, the rupture is inevitable.
Impending CBS is defined as short episodes of
bleeding which can resolve spontaneously or can be
controlled by simple packing. However complete
rupture is certain; only the time is unknown. Acute
CBS is defined as profuse bleeding which cannot be
controlled by simple packing. As there is a complete
and sudden rupture of the carotid artery, patient
deteriorates rapidly. Unless the vessel repair is
provided immediately, resuscitation would not help
for long term stabilization.1,4,8,16 Regarding the
spontaneous recovering recurrent epistxis attacks, our
case should be considered as an impending type of
CBS with pseudoaneurysm formation.
Management of CBS should depend on some
principles; the initial and cardinal priority is to
provide both respiratory and cardiac stabilization.
The next step should be identification of the site and
extent of the pathology via diagnostic angiography. 4
In case of carotid system involvement (internal or
common); temporary balloon occlusion test (BTO)
should be performed to determine intracranial
collateral circulation. The purpose of BTO is to
assess the availability of collateral circulation if the
ruptured carotid artery is permanently occluded.2,4
Balloon occlusion test is a decision making step not
only for endovascular treatment modalities but also
for the open surgery techniques. Emergent surgical
ligation of carotid system without BTO has average
neurologic morbidity of 60%.17 Prior to the neck
dissection procedure or irradiation of an extended
tumor invading carotid system; result of the BTO
may help to decide whether to ligate the vessel or to
construct a bypass.6 In literature; endovascular
modalities are more preferrable compared to surgical
management of CBS. Surgical management is usually
difficult as the exploration and repair of previously
irradiated fields is annoying.2,6 On the other hand,
endovascular techniques are less invasive. They can
be performed with local anesthesia and do not
necessitate any tissue harvesting.3,4,6,16
Based on the BTO result there are two main
types of endovascular treatment; de-constructive
versus constructive. Deconstructive management is
designed for the patients who can tolerate BTO and
are suitable for the permanent occlusion of carotid
artery by coil or glue embolization. Constructive
management is designed for the patients who can not
tolerate BTO therefore for patent and safe arterial
flow is provided by endovascular stents.2,4,11,15
Despite the BTO results, there are certain reports in
the literature stating cases who had passed the test
however developed ischemic complications including
cerebral infarction due to deconstructive
embolization procedure. The reason is thought to be
that BTO is a short timed- test (20-30 minutes) and
sometimes collateral circulation insufficency may be
seen in longer period.8
In case of nasopharyngeal cancer which is
irradiated, CBS is seen as a result of pseudoaneurysm
formation mainly in medium to large sized vessels on
a basis of atherosclerosis.7,9,10 Our patient had history
of ischemic cerebrovascular attack which gives
suspicion of tendency to thrombosis in a retrospective
fashion. As sson as pseudoaneurysm is detected on
angiography both deconstructive and constructive
endovascular modalities can be considered, however
each has its own limitations. Pseudoaneurysm is an
arterial bulging which is not baring normal vessel
wall structure. Besides surrounding bone is usually
ostoenecrotic which lacks any support mechanisms.
There can be acute rupture of pseudoaneurysm during
inflation of BTO balloon or stent replacement.11 Also
after embolization of pseudoaneurysm extravasation
of coils has been seen in some cases.7 To find a
solution; coil embolization with stent placement has
been worked on, but is been still controversial.8,18
106
Bahar KAYAHAN, MD; Nilda SÜSLÜ, MD; Cavid CABBARZADE, MD; Gamze ATAY, MD; Gözde YAZICI, MD; Ali
Şefik HOŞAL, MD
Carotid Blowout Syndrome During Radiotherapy: A Case Presentation and Review of A Rare Entity
KBB-Forum
2013;12(3)
www.KBB-Forum.net
Following endovascular procedures, there
might be recurrent hemorrhages which are found to
be correlated either with infection or anticoagulant
therapy. Therefore appropiate antibiotic treatment
should be administered after both deconctructive and
constructive procedures.2,15 Anticoagulant therapy is
generally started just before stent placement and
continued lifelong but much more intensive in the
first week. As a precaution, bleeding parameters
should be followed intimately, unnecessary
medication should be avoided when the optimum
level is reached.2,16
Carotid blowout syndrome might cause lethal
bleeding and it is better to realize risk factors in the
earlier period and to intervene if possible. It has been
noticed that focal soft tissue necrosis on Magnetic
Resonance Imaging of patients with nasopharyngeal
cancer is a predictor of CBS.9 Also both the
radiologist and the head neck cancer team (surgeon,
oncologist and radiation oncologist) should be alert
for pseudoaneurysm formation, vessel wall damages
and the degree of adjacent osteonecrosis to predict
any possible form of CBS.1,5
In conclusion; CBS is an uncommon but
lethal complication of head and neck cancer patients.
Not only the profuse hemorrhage, but also minimal
recurrent bleedings should be examined intimately.
Once it occurs, patient should be evaluated
immediately and proper treatment should be
administered quickly. As it is more important to
avoid such a catastrophic complication; predictors on
routine imaging techniques should not be missed and
fundamental precautions should be applied.
REFERENCES
1. Yanik B, Keyik B, Conkbayir I, Teber MA. Carotid
blowout syndrome with oronasal hemorrhage: magnetic
resonance imaging findings. Jpn J Radiol 2011
Jan;29(1):72-5.
2. Wan WS, Lai V, Lau HY, Wong YC, Poon WL, Tan CB.
Endovascular treatment paradigm of carotid blowout
syndrome: Review of 8-years experience. Eur J Radiol
2013 Jan;82(1):95-9.
3. Pathak KA, Viallet NR, Nason RW.
Sternocleidomastoid muscle interposition to prevent
carotid artery blowout. J Surg Oncol 2008 Dec
1;98(7):565-6.
4. Zussman B, Gonzalez LF, Dumont A, Tjoumakaris S,
Rosenwasser R, Hasan D, et al. Endovascular
Management of Carotid Blowout: Institutional
Experience and Literature Review. World Neurosurg
2012 Jul;78(1-2):109-14.
5. Luo CB, Teng MM, Chang FC. Radiation acute carotid
blowout syndromes of the ascending pharyngeal and
internal carotid arteries in nasopharyngeal carcinoma.
Eur Arch Otorhinolaryngol 2006 Jul;263(7):644-6.
6. Roh JL, Suh DC, Kim MR, Lee JH, Choi JW, Choi SH,
et al. Endovascular management of carotid blowout
syndrome in patients with head and neck cancers. Oral
Oncol 2008 Sep;44(9):844-50.
7. Cheng KM, Chan CM, Cheung YL, Chiu HM, Tang
KW, Law CK. Endovascular treatment of radiation-
induced petrous internal carotid artery aneurysm
presenting with acute haemorrhage. A report of two
cases. Acta Neurochir (Wien) 2001;143(4):351-5;
discussion 355-6.
8. Auyeung KM, Lui WM, Chow LC, Chan FL. Massive
epistaxis related to petrous carotid artery
pseudoaneurysm after radiation therapy: emergency
treatment with covered stent in two cases. AJNR Am J
Neuroradiol 2003 Aug;24(7):1449-52.
9. Chin SC, Jen YM, Chen CY, Som PM. Necrotic
nasopharyngeal mucosa: an ominous MR sign of a
carotid artery pseudoaneurysm. AJNR Am J
Neuroradiol 2005 Feb;26(2):414-6.
10. Li SH, Hsu SW, Wang SL, Chen HC, Huang CH.
Pseudoaneurysm of the external carotid artery branch
following radiotherapy for nasopharyngeal carcinoma.
Jpn J Clin Oncol 2007 Apr;37(4):310-3.
11. Chaloupka JC, Putman CM, Citardi MJ, Ross DA,
Sasaki CT. Endovascular therapy for the carotid
blowout syndrome in head and neck surgical patients:
diagnostic and managerial considerations. AJNR Am J
Neuroradiol 1996 May;17(5):843-52.
12. McDonald MW, Moore MG, Johnstone PA. Risk of
carotid blowout after reirradiation of the head and neck:
a systematic review. Int J Radiat Oncol Biol Phys 2012
Mar 1;82(3):1083-9.
13. Cengiz M, Ozyigit G, Yazici G, Dogan A, Yildiz F, Zorlu
F, et al. Salvage reirradiaton with stereotactic body
radiotherapy for locally recurrent head-and-neck
tumors. Int J Radiat Oncol Biol Phys 2011 Sep
1;81(1):104-9.
14. Kodani N, Yamazaki H, Tsubokura T, Shiomi H,
Kobayashi K, Nishimura T, et al. Stereotactic body
radiation therapy for head and neck tumor: disease
control and morbidity outcomes. J Radiat Res
2011;52(1):24-31.
15. Shah H, Gemmete JJ, Chaudhary N, Pandey AS, Ansari
SA. Acute life-threatening hemorrhage in patients with
head and neck cancer presenting with carotid blowout
syndrome: follow-up results after initial hemostasis with
covered-stent placement. AJNR Am J Neuroradiol 2011
Apr;32(4):743-7.
16. Chang FC, Lirng JF, Luo CB, Guo WY, Teng MM, Tai
SK, et al. Carotid blowout syndrome in patients with
head-and-neck cancers: reconstructive management by
self-expandable stent-grafts. AJNR Am J Neuroradiol
2007 Jan;28(1):181-8.
17. Chang FC, Lirng JF, Luo CB, Wang SJ, Wu HM, Guo
WY, et al. Patients with head and neck cancers and
associated postirradiated carotid blowout syndrome:
endovascular therapeutic methods and outcomes. J Vasc
Surg 2008 May;47(5):936-45
18. Wong GK, Poon WS. Why current evidence is against
flow diverters for treatment of carotid blowout
syndrome. Eur J Radiol 2013 Jan;82(1)
107
Article
Full-text available
Objective Epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC) is a common clinical critical illness, which often leads to death of patients. This article focuses on the relationship between massive epistaxis and pseudoaneurysm after radiotherapy in patients with NPC and discusses clinically relevant treatment strategies. Methods A review was performed in 21 patients with massive epistaxis after radiotherapy for NPC from January 2011 to December 2019, and all of the patients were examined by computed tomography angiography (CTA). We also reviewed the English literature over the past 10 years to analyze the characteristics and related causes of pseudoaneurysms in terms of the clinical stage of NPC, course of radiotherapy, and affected artery. An analysis was performed on the methods of endovascular interventional treatment of such pseudoaneurysms. Results Among the 21 patients, 19 cases had bone destruction of the skull base; 13 cases were also found to have tumor recurrence; 15 cases were in stage III or IV of NPC; pseudoaneurysms were observed in 14 cases, of which nine cases had pseudoaneurysms in the internal carotid artery (ICA), and the rest had pseudoaneurysms in the external carotid artery (ECA). These data were consistent with the results of the literature review. Analysis with imaging revealed that the petrous ICA was the common predilection site. There were 11 out of 14 cases of pseudoaneurysms with sentinel hemorrhage in the initial phase. All 14 pseudoaneurysm patients underwent endovascular interventional therapy, but one died from hemorrhagic shock during the procedure. No rebleeding was observed among the other patients during 72 h after intravascular treatment. Nevertheless, regrettably two patients died on the 10th and 17th days after intervention. Conclusion Pseudoaneurysm, which was a serious complication after radiotherapy in patients with NPC, could cause massive epistaxis with high mortality. The formation of a pseudoaneurysm was closely associated with a high carcinoma stage, re-radiotherapy, and local bone destruction and infection. Most cases had sentinel epistaxis, which was considered the bleeding characteristic. The imaging material prompted that pseudoaneurysm had a predisposition to the petrous part of the ICA, while the preferred therapy was endovascular embolization treatment.
Article
Full-text available
CSP in patients with HNC presenting with CBS can provide immediate hemostasis to prevent exsanguination. We evaluated the safety and efficacy of CSP to control acute life-threatening hemorrhage in patients with HNC presenting with CBS. We retrospectively reviewed 10 patients (7 men, 3 women; mean age, 59 years) with HNC presenting with acute life-threatening hemorrhage from CBS that was treated with CSP. We studied patient demographics, presentations, procedures, initial and delayed complications, and technical and clinical outcomes on follow-up. All patients achieved immediate hemostasis following CSP. Periprocedural complications consisted of groin hematomas (n=2), acute limb ischemia requiring thrombectomy, and an asymptomatic temporal lobe hemorrhage. Imaging and clinical follow-up were available for a mean of 17.7 months (range, 1-60 months). Two patients remained asymptomatic with a patent stent and no evidence of rebleeding at 17 and 21 months, respectively. Recurrent hemorrhages requiring retreatment were encountered in 3 patients secondary to stent infections (30%) at mean duration of 8 months. Neurologic morbidity resulted from stent thrombosis and stroke at 8 months in a single patient. Mortality was unrelated to CSP but was a result of palliative hospice care (n=3) at a mean of 2 months or natural disease progression (n=1) with documented patency of the stent at 6 months. Acute life-threatening hemorrhage from CBS related to advanced HNC can be safely and effectively treated with CSP. However, potential delayed ischemic or infectious complications are common in the exposed or infected neck.
Article
Full-text available
We evaluated the efficacy and safety of stereotactic body radiation therapy (SBRT) for patients with head and neck tumors. From April 2005 through April 2008, 34 patients with head and neck tumors were treated with CyberKnife SBRT. Twenty-one of them had prior radiotherapy. Treatment sites were orbit (n = 7), cervical lymph nodes (n = 6), nasopharynx (n = 5), oropharynx (n = 4) and others (n = 12). The prescribed dose ranged from 19.5 to 42 Gy (median, 30 Gy) in 3-8 fractions for consecutive days. The target volume ranged from 0.7 to 78.1 cm(3) (median, 11.6 cm(3)). The median follow-up was 16 months. Treatment was well tolerated without significant acute complications in any cases. Complete response rate and partial response rate were 32.4% and 38.6%, respectively. The overall survival rates were 70.6% and 58.3% at 12 and 24 months, respectively. The overall survival was better in patients without prior radiotherapy within the previous 24 months or in case of smaller target volume. Six patients suffered severe late complications. All these patients had prior radiotherapy, and 2 of them developed massive hemorrhage in the pharynx and both died of this complication 5 and 28 months, respectively, after SBRT. Our preliminary results suggest that SBRT is an effective treatment modality for head and neck tumors. However, re-irradiation has significant risk of severe and even fatal late complications in the form of necrosis and hemorrhage in re-irradiated areas.
Article
Full-text available
To review our institution's recent experience with patients with carotid blowout syndrome who were referred for emergency diagnostic angiography and endovascular therapy. Eighteen consecutive patients who had had surgery for cancer of the head and neck and in whom carotid blowout syndrome had occurred were referred to our service in accordance with a standardized protocol. Twenty-three angiographic pathoetiologic conditions were diagnosed in the 18 patients; the majority of these were pseudoaneurysms involving various segments of the carotid system. Multiple lesions were detected in five patients. Most patients were treated by means of permanent balloon occlusion; in 8 patients with either multiple lesions or impending rupture requiring flap reconstruction, a composite permanent balloon occlusion of the affected carotid system was performed. Hyperacute hemorrhages were arrested in all cases. Hemorrhages reoccurred in 2 cases, and in 2 patients who had permanent balloon occlusion of the internal carotid artery, transient ischemic attacks occurred, which appeared to be related to temporary collateral reserve failure. No permanent neurologic complications ensued. Our recent experience with carotid blowout syndrome suggests that this clinical diagnosis represents a heterogeneous group of angiographic pathoetiologies that the physician should evaluate carefully before proceeding with endovascular therapy. Specific endovascular approaches depend on the pathoetiologic mechanism of active or impending hemorrhage and the urgency with which intervention is required.
Article
Carotid blowout (CB) is a rare but frequently fatal complication of head-and-neck (H&N) cancer or its treatment. We sought to determine the reported rate of CB in patients receiving salvage reirradiation for H&N cancer. A literature search identified 27 published articles on H&N reirradiation involving 1554 patients, and a pooled analysis was performed to determine the rate of CB. Treatment parameters, including prior radiation dose, interval from prior radiation, dose and fractionation of reirradiation, use of salvage surgery, and chemotherapy, were abstracted and summarized. The cumulative risk of CB was compared between groups using Fisher's exact test. Among 1554 patients receiving salvage H&N reirradiation, there were 41 reported CBs, for a rate of 2.6%; 76% were fatal. In patients treated in a continuous course with 1.8-2-Gy daily fractions or 1.2-Gy twice-daily fractions, 36% of whom received concurrent chemotherapy, the rate of CB was 1.3%, compared with 4.5% in patients treated with 1.5 Gy twice daily in alternating weeks or with delayed accelerated hyperfractionation, all of whom received concurrent chemotherapy (p = 0.002). There was no statistically significant difference in the rate of CB between patients treated with or without concurrent chemotherapy, or between patients treated with or without salvage surgery before reirradiation. Carotid blowout is an infrequent but serious complication of salvage reirradiation for H&N cancer. The rate of CB was lower among patients treated with conventional or hyperfractionated schedules compared with regimens of accelerated hyperfractionation, though heterogeneous patient populations and treatment parameters preclude definite conclusions. Given the high mortality rate of CB, discussion of the risk of CB is an important component of informed consent for salvage reirradiation.
Article
Objectives: Endovascular treatment is effective in treating carotid blowout syndrome (CBS). We reviewed our experience in addressing CBS over eight years and presented an account of the treatment paradigm and management algorithm. Method: All cases of CBS from 2003 to 2010 with endovascular treatment performed in our center were reviewed. 15 CBS in 14 patients were recruited. Based on our management algorithm, treatment regimen was stratified into deconstructive or constructive methods. Their clinical presentations, angiographic features, angiographic and clinical outcomes were reviewed. Results: 10 patients were treated with deconstructive method by means of permanent vessel occlusion (PVO) and 4 patients were treated with constructive method by means of placement of covered stent (n=3) or flow diverting device (n=1). Immediate hemostasis was achieved in all cases. 7 (50%) patients, in whom 5 treated with PVO and 2 with covered stent, had favorable outcomes and survived at a median follow-up period of 4 months (range: 1-84 months). Conclusion: Permanent vessel occlusion remains the gold standard of treatment and tends to show a favorable long-term outcome. Off-label use of covered stent and flow-diverting device can produce satisfactory results should balloon occlusion test fail, but long-term follow up would be required for definitive assessment.
Article
Carotid blowout syndrome (CBS) is a rare but well-known complication of aggressive radiotherapy management of head and neck cancer. Reports on magnetic resonance imaging (MRI) findings of CBS are limited in the relevant literature, probably because of the angiography priority of this complication. We describe MRI findings in a patient with nasopharyngeal carcinoma complicated with CBS.
Article
In this study, we present our results of reirradiation of locally recurrent head-and-neck cancer with image-guided, fractionated, frameless stereotactic body radiotherapy technique. From July 2007 to February 2009, 46 patients were treated using the CyberKnife (Accuray, Sunnyvale, CA) at the Department of Radiation Oncology, Hacettepe University, Ankara, Turkey. All patients had recurrent, unresectable, and previously irradiated head-and-neck cancer. The most prominent site was the nasopharynx (32.6%), and the most common histopathology was epidermoid carcinoma. The planning target volume was defined as the gross tumor volume identified on magnetic resonance imaging and computed tomography. There were 22 female and 24 male patients. Median age was 53 years (range, 19-87 years). The median tumor dose with stereotactic body radiotherapy was 30 Gy (range, 18-35 Gy) in a median of five (range, one to five) fractions. Of 37 patients whose response to therapy was evaluated, 10 patients (27%) had complete tumor regression, 11 (29.8%) had partial response, and 10 (27%) had stable disease. Ultimate local disease control was achieved in 31 patients (83.8%). The overall survival was 11.93 months in median (ranged, 11.4-17.4 months), and the median progression free survival was 10.5 months. One-year progression-free survival and overall survival were 41% and 46%, respectively. Grade II or greater long-term complications were observed in 6 (13.3%) patients. On follow-up, 8 (17.3%) patients had carotid blow-out syndrome, and 7 (15.2%) patients died of bleeding from carotid arteries. We discovered that this fatal syndrome occurred only in patients with tumor surrounding carotid arteries and carotid arteries receiving all prescribed dose. Stereotactic body radiotherapy is an appealing treatment option for patients with recurrent head-and-neck cancer previously treated with radiation to high doses. Good local control with considerable 1-year survival is achieved with a relatively high rate of morbidity and related mortality.
Article
Carotid blow-out syndrome is the most dreaded complication in head and neck surgical oncology practice This article describes a simple technique of interposition of sternocleidomastoid muscle between pharynx and carotid sheath to isolate the latter from salivary contamination in the event of salivary leak. Authors have used this technique in 83 laryngectomies with excellent results.
Article
Haemorrhage from rupture of petrous ICA aneurysm can be life threatening and emergency treatment is required. We report 2 cases of radiation-induced petrous internal carotid artery (ICA) aneurysm presenting with acute haemorrhage (epistaxis and otorrhagia) after radiotherapy (RT) for nasopharyngeal carcinoma (NPC). Both patients had a history of RT treatment for NPC. The first patient, a 54-year-old man, presented with sudden severe epistaxis and haemorrhagic shock. The second patient, a 35-year-old man, presented with episodes of severe otorrhagia. The first patient was immediately resuscitated. Obliteration of the aneurysm was performed by endovascular occlusion of the ICA with Guglielmi detachable coils and fibered platinum coils. For the second patient, the aneurysm was treated by deploying a self-expandable stent across the aneurysm neck. In an emergency situation, ruptured petrous ICA aneurysm can be treated with endovascular occlusion of the ICA with microcoils if there is a good collateral blood flow. Alternatively, the aneurysm can be treated by deployment of a stent, which can induce stasis and eventual thrombosis of the aneurysm.